Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TC Energy
TRP
|
+$1.7B |
| 2 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$505M |
| 3 |
Johnson & Johnson
JNJ
|
+$441M |
| 4 |
Mastercard
MA
|
+$406M |
| 5 |
iShares US Real Estate ETF
IYR
|
+$394M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.61B |
| 2 |
NVIDIA
NVDA
|
+$1.42B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
Apple
AAPL
|
+$907M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$716M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.3% |
| 2 | Financials | 8.57% |
| 3 | Healthcare | 7.58% |
| 4 | Consumer Discretionary | 7.43% |
| 5 | Industrials | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
PUT
Las Vegas Sands
LVS
$29.6B
| $6.19M | ﹤0.01% |
123,000
| – | – |
|
3152
CALL
BioNTech
BNTX
$23.5B
| $6.19M | ﹤0.01% |
52,100
+35,200
| +208% | +$3.24M |
|
3153
Vanguard ESG International Stock ETF
VSGX
$6.74B
| $6.19M | ﹤0.01% |
100,559
-43,253
| -30% | -$2.55M |
|
3154
QCR Holdings
QCRH
$1.7B
| $6.18M | ﹤0.01% |
83,547
+34,588
| +71% | +$2.46M |
|
3155
First Trust Materials AlphaDEX Fund
FXZ
$398M
| $6.16M | ﹤0.01% |
91,956
+40,050
| +77% | +$2.59M |
|
3156
Invesco Food & Beverage ETF
PBJ
$107M
| $6.16M | ﹤0.01% |
127,441
+55,221
| +76% | +$2.56M |
|
|
UMH
3157
UMH Properties
UMH
$1.36B
| $6.15M | ﹤0.01% |
312,803
-256,676
| -45% | -$4.78M |
|
|
GLDD
3158
DELISTED
Great Lakes Dredge & Dock
GLDD
| $6.14M | ﹤0.01% |
583,155
+85,971
| +17% | +$799K |
|
3159
ICL Group
ICL
$6.85B
| $6.13M | ﹤0.01% |
1,441,445
-8,228
| -0.6% | -$34.9K |
|
|
JMIA
3160
Jumia Technologies
JMIA
$767M
| $6.11M | ﹤0.01% |
1,144,174
+237,200
| +26% | +$1.76M |
|
3161
Vanguard Consumer Staples ETF
VDC
$7.99B
| $6.09M | ﹤0.01% |
27,877
-8,102
| -23% | -$1.72M |
|
|
ACH
3162
Accendra Health
ACH
$214M
| $6.08M | ﹤0.01% |
387,669
+66,544
| +21% | +$1.01M |
|
3163
Zai Lab
ZLAB
$2.62B
| $6.07M | ﹤0.01% |
251,507
-44,452
| -15% | -$840K |
|
3164
MaxLinear
MXL
$6.8B
| $6.06M | ﹤0.01% |
418,732
+75,538
| +22% | +$1.2M |
|
3165
Allogene Therapeutics
ALLO
$694M
| $6.06M | ﹤0.01% |
2,162,603
+632,556
| +41% | +$1.69M |
|
3166
Alamo Group
ALG
$2.05B
| $6.05M | ﹤0.01% |
33,613
-12,078
| -26% | -$2.15M |
|
3167
Sutro Biopharma
STRO
$421M
| $6.04M | ﹤0.01% |
174,627
+69,690
| +66% | +$2.73M |
|
|
RVNC
3168
DELISTED
Revance Therapeutics, Inc.
RVNC
| $6.04M | ﹤0.01% |
1,163,371
+229,753
| +25% | +$1.14M |
|
3169
First Majestic Silver
AG
$9.07B
| $6.04M | ﹤0.01% |
1,006,038
-679,994
| -40% | -$3.94M |
|
3170
Ingevity
NGVT
$2.68B
| $6.03M | ﹤0.01% |
154,588
-40,078
| -21% | -$1.6M |
|
3171
CALL
Northern Oil and Gas
NOG
$2.35B
| $6.02M | ﹤0.01% |
+170,100
| New | +$6.49M |
|
|
3172
PUT
Northern Oil and Gas
NOG
$2.35B
| $6.02M | ﹤0.01% |
+170,100
| New | +$6.49M |
|
|
NVO
3173
PUT
Novo Nordisk
NVO
$209B
| $6.01M | ﹤0.01% |
50,500
-85,700
| -63% | -$11.4M |
|
3174
JELD-WEN Holding
JELD
$164M
| $6.01M | ﹤0.01% |
380,074
+59,104
| +18% | +$867K |
|
3175
Perspective Therapeutics
CATX
$342M
| $5.99M | ﹤0.01% |
+448,683
| New | +$5.97M |
|
Similar funds
Goldman Sachs's Q3 2024 Portfolio in Review
As of Q3 2024, Goldman Sachs held 6,216 positions worth $621B, up 5% from $591B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs's Q3 2024 filing shows 596 new, 2,752 increased, 1,995 reduced and 427 closed positions. Its largest new stake was Smurfit Westrock: 3,644,566 shares worth $180M. The largest sale was Tesla, an estimated $1.61B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
- Goldman Sachs's largest Q3 2024 buy was Smurfit Westrock: 3,644,566 shares worth $180M.
- Goldman Sachs added most to TC Energy in Q3 2024, an estimated $1.7B increase.
- Goldman Sachs's biggest Q3 2024 reduction was Tesla, cutting an estimated $1.61B.
- Goldman Sachs fully exited WestRock Company in Q3 2024, selling an estimated $204M.
- Goldman Sachs's ten largest holdings make up 19% of its $621B portfolio in Q3 2024.
- Goldman Sachs opened 596 new positions and closed 427 in Q3 2024.
- Goldman Sachs's portfolio value rose 5% quarter-over-quarter to $621B.
Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.